
Novo Nordisk Pharmatech, which is Danish pharmaceutical giant Novo Nordisk's supply-focused subsidiary, will establish a new sales office in the US in the course of 2021, according to the firm's annual report for 2020, in which the firm reveals that it will open up a sales office in Boston in the middle of this year.
Novo Nordisk Pharmatech's CEO Rasmus Hother le Fevre tells MedWatch that this is to ensure that the best possible service is provided to the firm's customers.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app